comparemela.com

Latest Breaking News On - Safety and efficacy - Page 1 : comparemela.com

ET Impact: DCGI asks pharma cos to adhere to production quality standards

The DCGI s move comes a few days after ET reported that industrial excipients are used in manufacturing medicines and over 50 companies manufacturing cough syrups have failed quality tests. The World Health Organization (WHO) said in October last year that the deaths of dozens of children in Gambia from acute kidney injuries might be linked to contaminated cough and cold syrups made by an Indian drug manufacturer.

The Future of Plaque Psoriasis Therapy

Expert dermatologists highlight the future of plaque psoriasis treatment, commenting on advances in therapy as well as increasing access to treatment.

Evaluating Work Productivity, Efficacy and Safety of Tildrakizumab in Patients With Plaque Psoriasis

Two posters presented at the 2023 Fall Clinical Dermatology Conference assessed phase 4 study findings on tildrakizumab in patients with moderate to severe plaque psoriasis.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.